Genetic: AAV5-RPGR ( DrugBank: - )

1 disease
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa2

90. Retinitis pigmentosa

Clinical trials : 130 /  Drugs : 180 - (DrugBank : 41) / Drug target genes : 49 - Drug target pathways : 109
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04794101
(ClinicalTrials.gov)		March 16, 202115/12/2020Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneFollow-up Phase 3 Randomized, Controlled Study of AAV5-RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneX-Linked Retinitis PigmentosaBiological: Genetic: AAV5-RPGR 4e11;Biological: Genetic: AAV5-RPGR 2e11MeiraGTx UK II LtdJanssen Research & Development, LLCRecruiting3 YearsN/AAll66Phase 3United States
2NCT04671433
(ClinicalTrials.gov)		March 16, 20215/11/2020Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GenePhase 3 Randomized, Controlled Study of AAV5-RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneX-Linked Retinitis PigmentosaBiological: Genetic: AAV5-RPGRMeiraGTx UK II LtdJanssen Research & Development, LLCRecruiting3 YearsN/AAll66Phase 3United States